company background image
EMBLA logo

Embla Medical hf CPSE:EMBLA Lagerbericht

Letzter Preis

DKK 31.00

Marktkapitalisierung

DKK 13.2b

7D

-0.6%

1Y

9.0%

Aktualisiert

26 Sep, 2024

Daten

Finanzdaten des Unternehmens +

Embla Medical hf.

CPSE:EMBLA Lagerbericht

Marktkapitalisierung: DKK 13.2b

EMBLA Aktienübersicht

Embla Medical hf. bietet zusammen mit ihren Tochtergesellschaften nicht-invasive orthopädische Produkte in Europa, dem Nahen Osten, Afrika, Nord- und Südamerika sowie im asiatisch-pazifischen Raum an.

Über das Unternehmen

EMBLA grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung3/6
Künftiges Wachstum2/6
Vergangene Leistung4/6
Finanzielle Gesundheit3/6
Dividenden0/6

Belohnungen

26% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt
Prognostiziertes Gewinnwachstum 17.87% pro Jahr
Die Erträge stiegen im vergangenen Jahr um 35.3%

Risikoanalyse

Hat einen hohen Schuldenstand

Embla Medical hf. Wettbewerber

Ambu

CPSE:AMBU B

DKK 34.7b

Demant

CPSE:DEMANT

DKK 57.1b

NuVasive

NasdaqGS:NUVA

US$2.1b

LeMaitre Vascular

NasdaqGM:LMAT

US$2.0b

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Embla Medical hf
Historische Aktienkurse
Aktueller AktienkursDKK 31.00
52-Wochen-HochDKK 35.70
52-Wochen-TiefDKK 25.25
Beta0.67
11 Monat Veränderung2.99%
3 Monate Veränderung5.08%
1 Jahr Veränderung8.96%
33 Jahre Veränderung-30.96%
5 Jahre Veränderung-35.88%
Veränderung seit IPO463.64%

Aktuelle Nachrichten und Updates

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Recent updates

Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Aug 22
Embla Medical hf.'s (CPH:EMBLA) Share Price Matching Investor Opinion

Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Jul 26
Earnings Beat: Embla Medical hf. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Jul 17
Calculating The Fair Value Of Embla Medical hf. (CPH:EMBLA)

Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

May 14
Market Participants Recognise Embla Medical hf.'s (CPH:EMBLA) Earnings

Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Apr 26
Embla Medical hf. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Apr 10
A Look At The Fair Value Of Embla Medical hf. (CPH:OSSR)

Is Össur hf (CPH:OSSR) Using Too Much Debt?

Mar 23
Is Össur hf (CPH:OSSR) Using Too Much Debt?

Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Jan 21
Why Investors Shouldn't Be Surprised By Össur hf.'s (CPH:OSSR) P/E

Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 03
Calculating The Intrinsic Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Nov 28
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

A Look At The Fair Value Of Össur hf. (CPH:OSSR)

Sep 23
A Look At The Fair Value Of Össur hf. (CPH:OSSR)

We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Aug 21
We Think Össur hf (CPH:OSSR) Is Taking Some Risk With Its Debt

Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Jul 18
Össur hf (CPH:OSSR) May Have Issues Allocating Its Capital

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Jun 14
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 19% Below Its Share Price

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

May 19
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Mar 14
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

Jan 21
A Look At The Intrinsic Value Of Össur hf. (CPH:OSSR)

These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

Dec 22
These 4 Measures Indicate That Össur hf (CPH:OSSR) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Dec 07
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Sep 21
Are Investors Undervaluing Össur hf. (CPH:OSSR) By 37%?

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Sep 02
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Aug 16
Össur hf (CPH:OSSR) Seems To Use Debt Quite Sensibly

Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Jun 16
Össur hf.'s (CPH:OSSR) Intrinsic Value Is Potentially 42% Above Its Share Price

Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Jun 01
Össur hf (CPH:OSSR) Will Want To Turn Around Its Return Trends

Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

May 08
Does Össur hf (CPH:OSSR) Have A Healthy Balance Sheet?

Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Feb 22
Össur hf (CPH:OSSR) Will Be Hoping To Turn Its Returns On Capital Around

Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Feb 03
Analysts Have Made A Financial Statement On Össur hf.'s (CPH:OSSR) Yearly Report

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Nov 25
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Oct 17
Returns On Capital Signal Tricky Times Ahead For Össur hf (CPH:OSSR)

Is Össur hf (CPH:OSSR) A Risky Investment?

Sep 28
Is Össur hf (CPH:OSSR) A Risky Investment?

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Aug 21
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Jul 11
Össur hf (CPH:OSSR) Might Be Having Difficulty Using Its Capital Effectively

Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

May 28
Here's Why Össur hf (CPH:OSSR) Can Manage Its Debt Responsibly

Calculating The Fair Value Of Össur hf. (CPH:OSSR)

May 07
Calculating The Fair Value Of Össur hf. (CPH:OSSR)

There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

Mar 25
There Are Reasons To Feel Uneasy About Össur hf's (CPH:OSSR) Returns On Capital

We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

Mar 02
We Think The Compensation For Össur hf.'s (CPH:OSSR) CEO Looks About Right

We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Feb 22
We Think Össur hf (CPH:OSSR) Can Stay On Top Of Its Debt

Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

Feb 09
Does The Market Have A Low Tolerance For Össur hf.'s (CPH:OSSR) Mixed Fundamentals?

What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Jan 26
What Kind Of Shareholders Own Össur hf. (CPH:OSSR)?

Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

Jan 08
Össur hf (CPH:OSSR) Shareholders Have Enjoyed An Impressive 115% Share Price Gain

We're Watching These Trends At Össur hf (CPH:OSSR)

Dec 21
We're Watching These Trends At Össur hf (CPH:OSSR)

Aktionärsrenditen

EMBLADK Medical EquipmentDK Markt
7D-0.6%-4.4%-4.7%
1Y9.0%14.5%21.8%

Rendite im Vergleich zur Industrie: EMBLA unter dem Niveau der Branche Danish Medical Equipment , die im vergangenen Jahr eine Rendite von 15.1% erzielte.

Rendite vs. Markt: EMBLA hinter dem Markt Danish zurück, der im vergangenen Jahr eine Rendite von 25.4 erzielte.

Preisvolatilität

Is EMBLA's price volatile compared to industry and market?
EMBLA volatility
EMBLA Average Weekly Movement3.8%
Medical Equipment Industry Average Movement5.5%
Market Average Movement4.3%
10% most volatile stocks in DK Market9.1%
10% least volatile stocks in DK Market2.5%

Stabiler Aktienkurs: EMBLA hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.

Volatilität im Zeitverlauf: EMBLADie wöchentliche Volatilität (5%) ist im vergangenen Jahr stabil geblieben.

Über das Unternehmen

GegründetMitarbeiterCEOWebsite
19714,000Sveinn Solvasonwww.emblamedical.com

Embla Medical hf. bietet zusammen mit ihren Tochtergesellschaften nicht-invasive orthopädische Produkte in Europa, dem Nahen Osten, Afrika, Nord- und Südamerika sowie im asiatisch-pazifischen Raum an. Das Unternehmen ist in drei Segmenten tätig: Prothetik, Orthesen und Bandagen sowie Patientenversorgung.

Embla Medical hf.'s Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Embla Medical hf im Vergleich zum Marktanteil des Unternehmens?
EMBLA grundlegende Statistiken
MarktanteilDKK 13.23b
Gewinn(TTM)DKK 408.10m
Umsatz(TTM)DKK 5.48b

32.5x

Kurs-Gewinn-Verhältnis

2.4x

Kurs-Umsatz-Verhältnis

Ist EMBLA zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
EMBLA Gewinn- und Verlustrechnung (TTM)
EinnahmenUS$819.70m
Kosten der EinnahmenUS$313.15m
BruttogewinnUS$506.55m
Sonstige AusgabenUS$445.45m
UmsatzUS$61.10m

Zuletzt gemeldete Gewinne

Jun 30, 2024

Datum des nächsten Gewinnberichts

Oct 23, 2024

Gewinn per Aktie (EPS)0.14
Bruttomarge61.80%
Nettogewinnspanne7.45%
Schulden/Eigenkapital-Verhältnis54.3%

Wie hat sich EMBLA auf lange Sicht entwickelt?

Historische Performance und Vergleiche